Betashares Crypto Innovators Etf (ASX:CRY) Share Price & Analysis
(ASX:CRY) Share Price Chart
About (ASX: CRY)
Cryosite Limited (ASX: CRY) is an Australian-based specialist logistics and biological storage company headquartered in South Granville, New South Wales. Listed on the Australian Securities Exchange, the company operates as a premier provider of outsourced supply chain solutions for the pharmaceutical, biotechnology, and medical research sectors. Its primary business focus is the management of temperature-sensitive biological assets, ensuring the integrity of high-value materials through rigorous quality control and specialized infrastructure.
The company’s core operations are centered on clinical trial logistics and biological specimen storage services. Cryosite manages the end-to-end supply chain for clinical trials, including the importation, specialized storage, secondary packaging, and distribution of investigational medicinal products to hospitals and research sites. Furthermore, the company maintains advanced cryogenic storage facilities used for cord blood and tissue banking, as well as the long-term preservation of diverse biological samples for commercial and academic institutions.
Cryosite occupies a unique market position as a pioneer in private cord blood banking in Australia and a trusted partner for global pharmaceutical companies. Its strategic focus involves expanding its footprint in the clinical trials market by capitalizing on the increasing complexity of biological therapies and the demand for specialized cold-chain expertise. The company’s value proposition is built on its extensive regulatory compliance, including TGA and GMP certifications, which provide clients with the security and reliability required for sensitive healthcare logistics.